Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

VIN Insider Trading (Value And Income Trust Plc (VIN.L))

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £97,784.34
Insider Selling (Last 12 Months): GBX 0

Value And Income Trust Plc (VIN.L) Insider Trading History Chart

This chart shows the insider buying and selling history at Value And Income Trust Plc (VIN.L) by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Value And Income Trust Plc (VIN.L) Share Price & Price History

Current Price: GBX 221
Price Change: Price Increase of +3.5 (1.61%)
As of 01/26/2021 10:00 PM ET

This chart shows the closing price history over time for VIN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today

Value And Income Trust Plc (VIN.L) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2020Josephine Clare ValentineInsiderBuy13,500GBX 198£26,730
10/30/2020Dominic NearyInsiderBuy162GBX 157£254.34
8/7/2020John KayInsiderBuy40,000GBX 177£70,800
7/15/2019Dominic NearyInsiderBuy9,820GBX 269£26,415.80
2/4/2019Matthew A OakeshottInsiderBuy25,000GBX 259£64,750
1/16/2019Matthew A OakeshottInsiderBuy40,000GBX 258£103,200
12/17/2018Matthew A OakeshottInsiderBuy50,000GBX 260£130,000
11/20/2018Matthew A OakeshottInsiderBuy50,000GBX 265£132,500
11/15/2018Matthew A OakeshottInsiderBuy100,000GBX 265£265,000
8/24/2018Matthew A OakeshottInsiderBuy75,000GBX 267£200,250
8/21/2018Matthew A OakeshottInsiderBuy50,000GBX 266£133,000
7/24/2018Matthew A OakeshottInsiderBuy50,000GBX 270£135,000
7/5/2018Matthew A OakeshottInsiderBuy17,500GBX 270£47,250
See Full Table
Insider Buying at Value And Income Trust Plc (VIN.L)?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Value And Income Trust Plc (VIN.L) and related companies.

SEC Filings (Institutional Ownership Changes) for Value And Income Trust Plc (VIN.L) (LON:VIN)

Value and Income Trust plc is a closed-ended equity mutual fund launched by Value & Income Services Limited. The fund is co-managed by OLIM Ltd. and OLIM Property Limited. It invests in the public equity markets of the United Kingdom. The fund also invests in convertible securities. It seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in dividend paying stocks of small and mid cap companies. The fund also directly invests in commercial property. It employs fundamental analysis with a focus on such factors as profitability, cash flows, balance sheets, management, and products and services to create its portfolio. The fund benchmarks the performance of its portfolio against the FTSE All-Share Index. Value and Income Trust plc was formed on April 19, 1972 and is domiciled in the United Kingdom.
Read More on Value And Income Trust Plc (VIN.L)

Today's Range

Now: GBX 221
Low: 212.36
High: 221.08

50 Day Range

MA: GBX 220.57
Low: 217.50
High: 221

52 Week Range

Now: GBX 221
Low: 148
High: 288

Volume

207,954 shs

Average Volume

101,319 shs

Market Capitalization

£99.06 million

P/E Ratio

N/A

Dividend Yield

5.25%

Beta

N/A

Who are the company insiders with the largest holdings of Value And Income Trust Plc (VIN.L)?

Value And Income Trust Plc (VIN.L)'s top insider shareholders include:
  1. Dominic Neary (Insider)
  2. John Kay (Insider)
  3. Josephine Clare Valentine (Insider)
Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today